Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

NewcelX Ltd. (NCEL)

$3.76 -1.18% NASDAQ: NCEL · 15-min delayed
  • Public · NASDAQ: NCEL
  • 4 employees
$15.8MMarket cap
-$8.3MNet income
4Employees
NCELNASDAQ
2021IPO

About NewcelX Ltd.

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$8.3M
Total assets
$11.4M
Market cap
$15.8M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: NCEL
$3.76 -1.18%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.88 $7.29

52-week range

Market cap
$15.8M
Shares outstanding
4.2M
Open
Day range
Prev close
Volume
IPO date
Jan 26, 2021

NewcelX Ltd. (NCEL) Stock Price

  • Reported a net loss of $8.3M.
  • Trading 48% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review NewcelX Ltd..

Write a review
Newsroom

News about NewcelX Ltd.

News & sentiment via Polygon.io

FAQ

NewcelX Ltd.: frequently asked questions

Is NewcelX Ltd. an American company?

NewcelX Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is NewcelX Ltd. publicly traded?

Yes — NewcelX Ltd. is a publicly traded company. Its stock trades under the ticker symbol NCEL on the NASDAQ.

What does NewcelX Ltd. do?

NewcelX Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →